Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Harvard Business School
Colorcon
Medtronic
AstraZeneca

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Biomarin Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?

BIOMARIN PHARM has two approved drugs.

There are eleven US patents protecting BIOMARIN PHARM drugs.

There are eighty patent family members on BIOMARIN PHARM drugs in twenty-four countries.

Summary for Biomarin Pharm
International Patents:80
US Patents:11
Tradenames:1
Ingredients:1
NDAs:2
Patent Litigation for Biomarin Pharm: See patent lawsuits for Biomarin Pharm

Drugs and US Patents for Biomarin Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes 8,067,416*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes 7,947,681*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 AB RX Yes Yes 8,067,416*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 AB RX Yes No 7,612,073*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride TABLET;ORAL 022181-001 Dec 13, 2007 RX Yes Yes 8,318,745*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-001 Dec 19, 2013 AB RX Yes Yes RE43797*PED   Start Trial Y   Start Trial
Biomarin Pharm KUVAN sapropterin dihydrochloride POWDER;ORAL 205065-002 Oct 27, 2015 AB RX Yes No 7,566,714*PED   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 100 mg ➤ Subscribe 2014-05-30
➤ Subscribe Powder for Oral Solution 500 mg/packet ➤ Subscribe 2016-12-20
➤ Subscribe Powder for Oral Solution 100 mg per packet ➤ Subscribe 2015-11-09
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
McKinsey
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.